![](/img/cover-not-exists.png)
Reduced cardiac side-effect potential by introduction of polar groups: Discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivo
Gebhard Thoma, Christian Beerli, Marc Bigaud, Christian Bruns, Nigel G. Cooke, Markus B. Streiff, Hans-Guenter ZerwesVolume:
18
Year:
2008
Language:
english
Pages:
6
DOI:
10.1016/j.bmcl.2008.01.108
File:
PDF, 160 KB
english, 2008